JVMIX | TASMX | JVMIX / TASMX | |
Total Expense Ratio | 0.87 | 0.80 | 109% |
Annual Report Gross Expense Ratio | 0.88 | 0.80 | 110% |
Fund Existence | 28 years | 10 years | - |
Gain YTD | 2.301 | -2.126 | -108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 21.5B | 624M | 3,446% |
Annual Yield % from dividends | 0.80 | 1.14 | 71% |
Returns for 1 year | -3.11 | -7.00 | 44% |
Returns for 3 years | 4.57 | -12.33 | -37% |
Returns for 5 years | 39.58 | 18.47 | 214% |
Returns for 10 years | 37.69 | 0.60 | 6,239% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 126.96 | 1.90 | +1.52% |
iShares Biotechnology ETF | |||
PSCT | 44.33 | 0.53 | +1.21% |
Invesco S&P SmallCap Info Tech ETF | |||
CDC | 63.17 | 0.59 | +0.94% |
VictoryShares US EQ Inc Enh Vol Wtd ETF | |||
EFAS | 17.63 | 0.05 | +0.28% |
Global X MSCI SuperDividend® EAFE ETF | |||
ARB | 28.30 | 0.01 | +0.04% |
AltShares Merger Arbitrage ETF |